AMERICAN CENTURY COMPANIES INC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN CENTURY COMPANIES INC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$16,087,000
+101.0%
173,084
+28.8%
0.01%
+100.0%
Q3 2021$8,004,000
-12.3%
134,412
+0.4%
0.01%
-16.7%
Q2 2021$9,128,000
+4.8%
133,840
+6.6%
0.01%0.0%
Q1 2021$8,711,000
-10.2%
125,535
-0.5%
0.01%
-25.0%
Q4 2020$9,697,000
-14.1%
126,213
-16.4%
0.01%
-20.0%
Q3 2020$11,293,000
-13.4%
150,991
-27.1%
0.01%
-16.7%
Q2 2020$13,047,000
+17.7%
207,258
-21.5%
0.01%
-7.7%
Q1 2020$11,085,000
-1.8%
263,933
+6.2%
0.01%
+18.2%
Q4 2019$11,290,000
+11.0%
248,570
+11.9%
0.01%
+10.0%
Q3 2019$10,167,000
-18.0%
222,129
+5.0%
0.01%
-16.7%
Q2 2019$12,404,000
+115.5%
211,568
+64.8%
0.01%
+100.0%
Q1 2019$5,756,000
+13.1%
128,405
-1.8%
0.01%0.0%
Q4 2018$5,091,000
-16.3%
130,697
-1.1%
0.01%0.0%
Q3 2018$6,082,000
+29.8%
132,168
+23.0%
0.01%
+20.0%
Q2 2018$4,684,000
+9.7%
107,427
-0.6%
0.01%
+25.0%
Q1 2018$4,269,000
+39.5%
108,071
+19.9%
0.00%
+33.3%
Q4 2017$3,061,000
+84.7%
90,102
+38.6%
0.00%
+50.0%
Q3 2017$1,657,000
+311.2%
64,994
+171.8%
0.00%
Q2 2017$403,00023,9120.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders